Ticagrelor Versus Clopidogrel in Older Patients with NSTE-ACS Using Oral Anticoagulation: A Sub-Analysis of the POPular Age Trial

Ticagrelor Versus Clopidogrel in Older Patients with NSTE-ACS Using Oral Anticoagulation: A Sub-Analysis of the POPular Age Trial

There are no randomised data on which antiplatelet agent to use in elderly patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) and an indication for oral anticoagulation (OAC). The randomised POPular Age trial, in patients of 70 years or older with NSTE-ACS, showed a reduction in bleed...

Full description

Bibliographic Details
Main Authors: Marieke E. Gimbel, Anne H. Tavenier, Wilbert Bor, Renicus S. Hermanides, Evelyn de Vrey, Ton Heestermans, Melvyn Tjon Joe Gin, Reinier Waalewijn, Sjoerd Hofma, Frank den Hartog, Wouter Jukema, Clemens von Birgelen, Michiel Voskuil, Johannes Kelder, Vera Deneer, Jurriën M. ten Berg
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Journal of Clinical Medicine
Subjects:
non-ST-segment elevation myocardial infarction (NSTEMI)
elderly
non-vitamin K oral anticoagulation (NOAC)
vitamin K antagonists (VKA)
ticagrelor
clopidogrel
Online Access:https://www.mdpi.com/2077-0383/9/10/3249

Internet

https://www.mdpi.com/2077-0383/9/10/3249

Similar Items